MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Net Income
$37,890K
EPS
$0.6
Unit: Thousand (K) dollars

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Impairment of intangible assets
NaN -649* 0 58,710
Revenue, net
36,220 34,125 26,063 25,881
Cost of product revenue
1,897 1,520 1,238 12,379
Intangible asset amortization
316 966* 315 1,616
Gain on sale of future royalties, intellectual property, and other assets, net
43,314 NaN NaN NaN
Research and development
4,392 2,620 3,432 3,433
Selling, general and administrative
20,783 20,354 16,935 20,782
Total operating expenses
25,175 22,974 20,367 24,215
Income (gain) from operations
52,146 9,315 4,143 -71,039
Loss on extinguishment of debt
-2,756 NaN NaN NaN
Loss on sale of prv
NaN -6,195* 0 148,325
Loss on derivative liability
-7,216 NaN NaN NaN
Interest expense
1,711 1,887* 2,051 2,009
Fair value adjustment related to warrant and cvr liability
-968 -11,557* 5,506 747
Fair value adjustment related to investments
216 34* -124 2
Interest and other income, net
3,589 -90* 2,313 2,378
Total other (expense) income
-7,342 3,351 -5,120 147,945
Income (loss) before income taxes
44,804 12,666 -977 76,906
Income tax expense
6,914 501 -433 2,199
Net income (loss)
37,890 12,165 -544 74,707
Basic EPS
0.62 0.216 -0.01 1.24
Diluted EPS
0.6 0.204 -0.01 1.21
Basic Average Shares
58,405,955 56,417,179 55,951,572 54,780,938
Diluted Average Shares
60,230,490 59,511,670 55,951,572 56,324,903
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Gain on sale of futureroyalties, intellectual...$43,314K Revenue, net$36,220K (77.54%↑ Y/Y)Income (gain) fromoperations$52,146K (1072.51%↑ Y/Y)Total operatingexpenses$25,175K (10.40%↑ Y/Y)Cost of productrevenue$1,897K (41.04%↑ Y/Y)Intangible assetamortization$316K (-80.43%↓ Y/Y)Income (loss) beforeincome taxes$44,804K (2437.19%↑ Y/Y)Total other (expense)income-$7,342K (-313.12%↓ Y/Y)Interest and otherincome, net$3,589K Selling, general andadministrative$20,783K (6.33%↑ Y/Y)Research and development$4,392K (34.81%↑ Y/Y)Fair valueadjustment related to...-$968K Net income (loss)$37,890K (1322.65%↑ Y/Y)Income tax expense$6,914K (484.94%↑ Y/Y)Loss on derivativeliability-$7,216K Loss onextinguishment of debt-$2,756K Interest expense$1,711K Fair valueadjustment related to...$216K

ZEVRA THERAPEUTICS, INC. (ZVRA)

ZEVRA THERAPEUTICS, INC. (ZVRA)